Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
November 05, 2026 by regulatorwatch.com
FDA Signals PMTA Overhaul, But Will It Deliver?
The FDA's proposed overhaul of its Premarket Tobacco Product Application (PMTA) process has renewed hopes for a more predictable regulatory pathway for vaping products in the United States.
Years of shifting scientific requirements, widespread application denials and regulatory uncertainty have created significant challenges for independent manufacturers. Industry representatives are now calling for clearer approval standards and a workable framework for flavoured e-cigarettes.
The proposed reforms could help strengthen the legal vaping market while supporting tobacco harm reduction. However, their success will depend on whether regulatory changes translate into timely, evidence-based decisions and improved access to lower-risk alternatives for adult smokers.
November 05, 2026 by tobaccoasia.com
US FDA Rethinks the Continuum of Risk
The US FDA is signalling a shift towards recognising the continuum of risk in tobacco and nicotine regulation.
At the Global Tobacco and Nicotine Forum in Lisbon, the agency outlined plans to accelerate product authorisations, reconsider its approach to flavoured e-cigarettes and improve communication about the relative risks of nicotine products.
The proposed changes also place greater emphasis on helping adults who smoke switch to lower-risk alternatives while maintaining safeguards against youth uptake. Integrating tobacco harm reduction into regulatory decisions could represent an important development in US tobacco control policy.
November 04, 2026 by centerforglobalhealthaccountability.org
Beyond Smoking
Nicotine's future may extend beyond its traditional role as a smoking cessation aid. As cigarette use declines, a growing market for smoke-free nicotine products raises questions about consumer choice, regulation and the long-term place of nicotine in society.
A new policy analysis proposes a separate US regulatory framework for lower-risk consumer nicotine products, distinguishing them from combustible tobacco and medicinal nicotine.
The approach emphasises proportionate safety standards, accurate information and age restrictions, while recognising that tobacco harm reduction and informed adult consumer choice are related but distinct policy considerations.
November 04, 2026 by centerforglobalhealthaccountability.org
Beyond Smoking
Nicotine's future may extend beyond its traditional role as a smoking cessation aid. As cigarette use declines, a growing market for smoke-free nicotine products raises questions about consumer choice, regulation and the long-term place of nicotine in society.
A new policy analysis proposes a separate US regulatory framework for lower-risk consumer nicotine products, distinguishing them from combustible tobacco and medicinal nicotine.
The approach emphasises proportionate safety standards, accurate information and age restrictions, while recognising that tobacco harm reduction and informed adult consumer choice are related but distinct policy considerations.
November 02, 2026 by substack.com
Mice studies to simulate children exposure to “third hand” vaping are toxicological fiction
Eight mouse studies examining children's potential exposure to residual vaping aerosol have raised questions about the reliability of experimental models used in nicotine research.
A detailed methodological review identifies unusually high aerosol concentrations, outdated devices and exposure conditions that may not reflect everyday environments. These limitations complicate the interpretation of laboratory findings and their relevance to human health.
The analysis highlights the importance of realistic exposure assessment and scientific rigour, particularly when animal studies are used to inform public health messaging and tobacco harm reduction policy.
November 02, 2026 by medium.com
Cobra Effect and the End of Age of Cigarettes
US cigarette sales are declining two to three times faster than their historical trend, raising questions about the future of tobacco control as smoking becomes less common.
Despite this progress, cigarette taxes and legal settlement payments remain important sources of state revenue, while only a small proportion is allocated to smoking prevention and cessation programmes.
These financial arrangements raise concerns about potential unintended incentives in tobacco policy. Public health priorities should remain focused on reducing smoking-related deaths, supporting cessation and ensuring access to lower-risk nicotine alternatives.
November 02, 2026 by regulatorwatch.com
Bleed Us Dry | Vape Veteran on Big Tobacco’s Campaign to Crush Vaping | RegWatch
Regulatory uncertainty is placing increasing pressure on independent vaping businesses across the United States. Restrictions affecting shipping, payment processing and online sales are creating significant operational challenges for companies serving adult smokers.
An industry veteran with 18 years of experience describes these pressures as part of a broader effort by major tobacco companies to undermine independent competitors.
The concerns raise important questions about market competition and tobacco harm reduction. Clear, workable regulation is essential to supporting responsible businesses and preserving access to lower-risk alternatives for adults seeking to quit smoking.
October 29, 2026 by regulatorwatch.com
No Clear Rules | Mi-Pod’s Finance Chief on Uncertainty Facing U.S. Vaping | RegWatch
Unclear federal regulations and conflicting state restrictions are creating significant challenges for US vaping businesses, affecting compliance, financial planning and long-term stability.
Rebecca Basinski, Mi-Pod’s Vice President of Finance and Accounting, shares how regulatory uncertainty has affected the company’s operations, including a crisis that nearly forced it into bankruptcy.
Her experience highlights the importance of transparent and consistent regulation that supports responsible businesses, protects adult consumers and maintains access to lower-risk alternatives for smokers.
October 28, 2026 by thr101.org
Youth Vaping Drops While Smoke-Free Alternatives Gain Ground Among Arizona Adults
Arizona's adult smoking rate has fallen to a historic low of 7.7%, while vaping now exceeds smoking among adults for the first time. At the same time, youth vaping has declined substantially over the past decade, according to newly released survey data.
These trends suggest that declining youth nicotine use and greater adoption of smoke-free alternatives among adults can occur simultaneously, although they do not establish a causal relationship.
As Arizona considers further nicotine regulations, the findings highlight the importance of protecting young people while recognising the potential role of vaping in helping adults move away from combustible cigarettes.
October 27, 2026 by vietnam.vn
Smokeless products: Science doesn't wait for policy.
Scientific research on smoke-free nicotine products continues to advance, even in countries where these products face restrictions or outright bans.
Singapore, Thailand and Australia continue to examine consumer behaviour and regulatory outcomes, while research from Japan and the United States is contributing to a better understanding of toxicant exposure and potential health effects.
For Vietnam, these international experiences highlight the importance of ongoing scientific evaluation. Distinguishing between nicotine products, assessing relative risks and monitoring real-world outcomes can support more informed tobacco control policies without overlooking the uncertainties surrounding long-term health effects.
- Page 1 of 172